Literature Citations
1. Investigating Ghanaian Allium Species for Anti-infective and Resistance-reversal Natural Product Leads to Mitigate Multidrug-resistance in Tuberculosis. Danquah, C.A., M. Tetteh, I.K. Amponsah, A.Y. Mensah, K.O. Buabeng, S. Gibbons, and S. Bhakta. Antibiotics, 2021. 10(8): 902. PMID[34438951]. PMCID[PMC8388710].
[PubMed]. TB_09_2021.
2. Isolation of Bioactive Compounds from Medicinal Plants Used in Traditional Medicine: Rautandiol B, a Potential Lead Compound against Plasmodium falciparum. Dawurung, C.J., M.T.H. Nguyen, J. Pengon, K. Dokladda, R. Bunyong, R. Rattanajak, S. Kamchonwongpaisan, P.T.M. Nguyen, and S.G. Pyne. BMC Complementary Medicine and Therapies, 2021. 21(1): 231. PMID[34517853]. PMCID[PMC8438977].
[PubMed]. TB_09_2021.
3. Synthesis and Evaluation of Antimycobacterial Activity of Riboflavin Derivatives. Harale, B., S. Kidwai, D. Ojha, M. Singh, D.K. Chouhan, R. Singh, V. Khedkar, and A.B. Rode. Bioorganic & Medicinal Chemistry Letters, 2021. 48: 128236. PMID[34242760].
[PubMed]. TB_09_2021.
4. Synthesis and Antimycobacterial Activity of 3-Phenyl-1H-indoles. Jardim Etchart, R., R.S. Rambo, B. Lopes Abbadi, N. Sperotto, C. Ev Neves, F. Fries Silva, M. Dornelles, L. Duarte, F. Souza Macchi, M. Alberton Perelló, R. Vescia Lourega, C. Valim Bizarro, L.A. Basso, and P. Machado. Molecules, 2021. 26(17): 5148. PMID[34500579]. PMCID[PMC8433792].
[PubMed]. TB_09_2021.
5. 1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis. Khonde, L.P., R. Müller, G.A. Boyle, V. Reddy, A.T. Nchinda, C.J. Eyermann, S. Fienberg, V. Singh, A. Myrick, E. Abay, M. Njoroge, N. Lawrence, Q. Su, T.G. Myers, H.I.M. Boshoff, C.E. Barry, 3rd, F.A. Sirgel, P.D. van Helden, L.M. Massoudi, G.T. Robertson, A.J. Lenaerts, G.S. Basarab, S.R. Ghorpade, and K. Chibale. Journal of Medicinal Chemistry, 2021. 64(17): p. 12790-12807. PMID[34414766].
[PubMed]. TB_09_2021.
6. E-pharmacophore Model-guided Design of Potential Dpre1 Inhibitors: Synthesis, in Vitro Antitubercular Assay and Molecular Modelling Studies. Kumar, A., R. Rajappan, S.G. Kini, E. Rathi, S. Dharmarajan, and K.S.R. Pai. Chemical Papers, 2021. 75(10): p. 5571-5585. ISI[000687249000044].
[WOS]. TB_09_2021.
7. N-Thio-Β-lactams Targeting L,D-transpeptidase-2, with Activity against Drug-resistant Strains of Mycobacterium tuberculosis. Martelli, G., T.B. Pessatti, E.M. Steiner, M. Cirillo, C. Caso, F. Bisognin, M. Landreh, P.D. Monte, D. Giacomini, and R. Schnell. Cell Chemical Biology, 2021. 28(9): p. 1321-1332.e1325. PMID[33826941].
[PubMed]. TB_09_2021.
8. In Vitro Synergism of Six Antituberculosis Agents against Drug-resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients. Ying, R., X. Huang, Y. Gao, J. Wang, Y. Liu, W. Sha, and H. Yang. Infection and Drug Resistance, 2021. 14: p. 3729-3736. PMID[34548797]. PMCID[PMC8449861].
[PubMed]. TB_09_2021.
Patent Citations
9. Oxazolidinone Compound and Methods of Use Thereof as an Antibacterial Agent. Crowley, B.M., P. Nantermet, D.B. Olsen, T. Suzuki, L. Yang, and L. You. Patent. 2021. 2021-US22652 2021188606: 34pp.
[Patent]. TB_09_2021.
10. Acetyl-CoA-Transferase (ACC) Inhibitors for Use in Treating Mycobacterial Diseases. Reiling, N. and J. Brandenburg. Patent. 2021. 2021-17226157 20210290629: 23pp , Cont -in-part of U S Ser No 315,017.
[Patent]. TB_09_2021.
11. Novel N-Aryl oxamic acids. Zhang, Z.-Y. and K.V. Ruddraraju. Patent. 2021. 2021-17163650 20210309606.
[Patent]. TB_09_2021.